loader
Please Wait
Applying Filters...

Minakem Generic APIs Minakem Generic APIs

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Elocalcitol, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Elocalcitol

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    2D Structure
    1. Also known as: 199798-84-0, Bxl 628, Elocalcitol [inn], Bxl-628, Ro-26-9228, 2wds5f2v6q
    Molecular Formula
    C29H43FO2
    Molecular Weight
    442.6  g/mol
    InChI Key
    LRLWXBHFPGSUOX-GJQYOBCGSA-N
    FDA UNII
    2WDS5F2V6Q
    Elocalcitol is a calcitriol analog for inhibition of prostate cell growth; in phase II clinical trial in patients with benign prostate hyperplasia (4/2004).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (1R,3Z,5S)-3-[(2E)-2-[(3aS,7aS)-1-[(E,2S)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol
    2.1.2 InChI
    InChI=1S/C29H43FO2/c1-6-29(32,7-2)17-8-10-20(3)25-14-15-26-22(11-9-16-28(25,26)5)12-13-23-18-24(31)19-27(30)21(23)4/h8,12-14,17,20,24,26-27,31-32H,4,6-7,9-11,15-16,18-19H2,1-3,5H3/b17-8+,22-12+,23-13-/t20-,24+,26-,27-,28+/m0/s1
    2.1.3 InChI Key
    LRLWXBHFPGSUOX-GJQYOBCGSA-N
    2.1.4 Canonical SMILES
    CCC(CC)(C=CCC(C)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)F)O)C)O
    2.1.5 Isomeric SMILES
    CCC(CC)(/C=C/C[C@H](C)C1=CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)F)O)C)O
    2.2 Other Identifiers
    2.2.1 UNII
    2WDS5F2V6Q
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Bxl-628

    2. Bxl628

    2.3.2 Depositor-Supplied Synonyms

    1. 199798-84-0

    2. Bxl 628

    3. Elocalcitol [inn]

    4. Bxl-628

    5. Ro-26-9228

    6. 2wds5f2v6q

    7. Ro 26-9228

    8. (1r,3z,5s)-3-[(2e)-2-[(3as,7as)-1-[(e,2s)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3h-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol

    9. Bxl628

    10. Unii-2wds5f2v6q

    11. Elocalcitol [mart.]

    12. Gtpl2785

    13. Schembl12932254

    14. Zha79884

    15. Zinc4802676

    16. 1alpha-fluoro-25-hydroxy-16,23e-diene-26,27-bishomo-20-epi-cholecalciferol

    17. Akos025312296

    18. Db06194

    19. Hy-32345

    20. Cs-0001526

    21. J3.510.012a

    22. E98793

    23. 798e840

    24. Q27077174

    25. 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3

    26. (1r,5s,z)-3-((e)-2-((3as,7as)-3-((s,e)-6-ethyl-6-hydroxyoct-4-en-2-yl)-3a-methyl-3a,4,5,6-tetrahydro-1h-inden-7(7ah)-ylidene)ethylidene)-5-fluoro-4-methylenecyclohexanol

    27. 1s,3r,5z,7e,23e)-1-fluoro-26,27-dihomo-9,10-secocholesta-5,7,10(19),16,23-pentaene-3,25-diol

    28. Cyclohexanol, 3-((1-(5-ethyl-5-hydroxy-1-methyl-3-heptenyl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4h-inden-4-ylidene)ethylidene)-5-fluoro-4-methylene-, (3as-(1(1r*,3e),3aalpha,4e(1s*,3z,5r*),7abeta))-

    29. Cyclohexanol, 3-((2e)-((3as,7as)-1-((1s,3e)-5-ethyl-5-hydroxy-1-methyl-3-heptenyl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4h-inden-4-ylidene)ethylidene)-5-fluoro-4-methylene-, (1r,3z,5s)-

    2.4 Create Date
    2006-10-26
    3 Chemical and Physical Properties
    Molecular Weight 442.6 g/mol
    Molecular Formula C29H43FO2
    XLogP35.7
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count7
    Exact Mass442.32470877 g/mol
    Monoisotopic Mass442.32470877 g/mol
    Topological Polar Surface Area40.5 Ų
    Heavy Atom Count32
    Formal Charge0
    Complexity813
    Isotope Atom Count0
    Defined Atom Stereocenter Count5
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count3
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in benign prostatic hyperplasia, urinary incontinence, prostate disorders, and infertility.

    Treatment of benign prostatic hyperplasia

    Post Enquiry
    POST ENQUIRY